The harm-to-benefit ratio of FIT-based screening is higher among individuals without vs with previously detectable f-Hb.
Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, ...
Although the incidence of spontaneous bacterial empyema in patients with cirrhosis is low, SPEM in this population is associated with a 90-day mortality rate of 41%. Albumin may reduce mortality in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback